Literature DB >> 19341938

Alopecia areata: evidence-based treatments.

Seema Garg1, Andrew G Messenger.   

Abstract

Alopecia areata is a common condition causing nonscarring hair loss. It may be patchy, involve the entire scalp (alopecia totalis) or whole body (alopecia universalis). Patients may recover spontaneously but the disorder can follow a course of recurrent relapses or result in persistent hair loss. Alopecia areata can cause great psychological distress, and the most important aspect of management is counseling the patient about the unpredictable nature and course of the condition as well as the available effective treatments, with details of their side effects. Although many treatments have been shown to stimulate hair growth in alopecia areata, there are limited data on their long-term efficacy and impact on quality of life. We review the evidence for the following commonly used treatments: corticosteroids (topical, intralesional, and systemic), topical sensitizers (diphenylcyclopropenone), psoralen and ultraviolet A phototherapy (PUVA), minoxidil and dithranol.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19341938     DOI: 10.1016/j.sder.2008.12.002

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  15 in total

1.  HLA antigens in individuals with down syndrome and alopecia areata.

Authors:  Juliany L Estefan; Juliana C Oliveira; Eliane D Abad; Simone B Saintive; Luis Cristóvão Ms Porto; Marcia Ribeiro
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

Review 2.  Efficacy of fractional lasers in treating alopecia: a literature review.

Authors:  Marina Perper; Adam S Aldahan; Rachel A Fayne; Christopher P Emerson; Keyvan Nouri
Journal:  Lasers Med Sci       Date:  2017-08-16       Impact factor: 3.161

3.  Prevention and treatment of alopecia areata with quercetin in the C3H/HeJ mouse model.

Authors:  Tongyu Cao Wikramanayake; Alexandra C Villasante; Lucia M Mauro; Carmen I Perez; Lawrence A Schachner; Joaquin J Jimenez
Journal:  Cell Stress Chaperones       Date:  2011-11-01       Impact factor: 3.667

4.  Screening for associated autoimmune disorders in Polish patients with Addison's disease.

Authors:  Marta Fichna; Piotr Fichna; Maria Gryczyńska; Jarosław Walkowiak; Magdalena Zurawek; Jerzy Sowiński
Journal:  Endocrine       Date:  2010-03-16       Impact factor: 3.633

5.  Intralesional steroids for alopecia areata.

Authors:  M Kumaresan
Journal:  Int J Trichology       Date:  2010-01

6.  Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells.

Authors:  Ibrahim A Aljuffali; Calvin T Sung; Feng-Ming Shen; Chi-Ting Huang; Jia-You Fang
Journal:  AAPS J       Date:  2013-12-04       Impact factor: 4.009

7.  Vitiligo and alopecia areata: apples and oranges?

Authors:  John E Harris
Journal:  Exp Dermatol       Date:  2013-12       Impact factor: 3.960

8.  Diphencyprone induced vitiligo: a case report.

Authors:  Mohammad Ali Nilforoushzadeh; Gelavizh Keshtmand; Fariba Jaffary; Abbas Kheirkhah
Journal:  Case Rep Med       Date:  2012-07-01

9.  The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias.

Authors:  Karzan G Khidhir; David F Woodward; Nilofer P Farjo; Bessam K Farjo; Elaine S Tang; Jenny W Wang; Steven M Picksley; Valerie A Randall
Journal:  FASEB J       Date:  2012-10-26       Impact factor: 5.191

Review 10.  Female pattern alopecia: current perspectives.

Authors:  Lauren L Levy; Jason J Emer
Journal:  Int J Womens Health       Date:  2013-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.